Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
DGNMF
)
0.0297
UNCHANGED
Delayed Quote
Updated: 10:44 AM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DGNMF
< Previous
1
2
Next >
DiagnaMed Advancing the Medical Potential of Hydrogen
October 30, 2024
Focusing on novel molecular hydrogen therapies for brain health
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Expands with Drug and Clinical Research AI Platform
August 21, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
August 15, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces LIFE Offering of up to $650,000
May 15, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
May 15, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
April 25, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
April 23, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
April 03, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
March 20, 2024
BRAIN AGE® solution is part of the CERVAI™ Brain Health AI Platform
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
March 14, 2024
Potential $150,000 in non-dilutive funding support through IPON and IP Assist Programs
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
March 11, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
February 28, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
January 17, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
November 15, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
October 03, 2023
Program provides healthcare providers access to Diagnamed’s novel brain health AI platform
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
September 13, 2023
A world first, CERVAI™ on track for commercialization in Q4-2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
June 20, 2023
CERVAI™ entering final development stage and readying for commercialization in Q4-2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
May 25, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
May 17, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
May 10, 2023
Focused on Health GenAI and CERVAI™, a generative AI brain health platform
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
May 03, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
